Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram, Hypotonia, Pulse absent, Respiratory arrest
Clinical narrative: Cardiac arrest; arrhythmia; congestive heart failure; Difficult Breathing; This is a spontaneous report from a contactable consumer.   A 81-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 12Jan2021 16:00 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included diabetes, hip replacement, back surgery , Heart disorder, thyroid disorder, neuropathy, blood cholesterol abnormal, blood pressure abnormal, infection, bone density abnormal, pain. Concomitant medications included acetylsalicylic acid (ASPRIN) taken for an unspecified indication, start and stop date were not reported; naproxen sodium (ALEVE) taken for pain, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported; insulin glargine (BASAGLAR) taken for Diabetic Therapy, start and stop date were not reported; cephalexin (CEPHALEXIN) taken for infection, start and stop date were not reported; duloxetine hydrochloride (CYMBALTA) taken for neuropathy, start and stop date were not reported; duloxetine (DULOXETINE) taken for neuropathy, start and stop date were not reported; gabapentin (GABAPENTIN) taken for neuropathy, start and stop date were not reported; fosinopril sodium (FOSINOPRIL SODIUM) taken for blood cholesterol abnormal, start and stop date were not reported; levothyroxine sodium (LEVOXYL) taken for thyroid disorder, start and stop date were not reported; metoprolol succinate (METOPROLOL SUCCINATE) taken for Heart Beta block, start and stop date were not reported; omeprazole (OMERAZOLE) taken for an unspecified indication, start and stop date were not reported; pravastatin sodium (PRAVASTATIN SODIUM) taken for blood cholesterol abnormal, start and stop date were not reported; propranolol (PROPRANOLOL) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for thyroid disorder, start and stop date were not reported; hydrochlorothiazide, triamterene (TRIAMTERENE/HCTZ) taken for blood pressure abnormal, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported; calcium, colecalciferol (CALCIUM + D3) taken for bone density abnormal, start and stop date were not reported; cyanocobalamin (B-12) taken for an unspecified indication, start and stop date were not reported; vitamin c [ascorbic acid] (VITAMIN C ) taken for an unspecified indication, start and stop date were not reported.  The patient experienced difficult breathing on 15Jan2021 admitted to ER with congestive heart failure. On 18Feb2021 had a Cardiac arrest and died on 22Feb2021. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Patient died. Number of days hospitalisation: 6. Date of death was 22Feb2021 and death cause was cardiac arrest after arrhythmia. No other vaccine in four weeks. No COVID prior vaccination, no COVID tested post vaccination. Therapeutic measures taken as a result of the events was Lasix, TEE and other tests, on respirator.  The patient died on 22Feb2021.  An autopsy was not performed.  Information on the lot/ batch number has been requested.; Reported Cause(s) of Death: cardiac arrest after arrhythmia; cardiac arrest after arrhythmia